By the criteria applied from this work, ER should also be classified as a tumor suppressor, as its promoter and locus are commonly hypermethylated in breast cancer, and because this is the primary mechanism through which ER protein expression is silenced in breast cancer [55], occurring in as many as one of three cases of breast cancer. Here, ESR1 is linked to neoplasm.